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Tetanus continues to represent a serious health problem 
in developing countries [1,2]. Although tetanus is a rare 
disease in the developed countries [3] ,  it is still common 
enough to cause concern in Turkey. During the years 
1992-3, 75 deaths caused by tetanus were reported 
from Turkey [4]. Clinical details of 88 adult patients 
with tetanus who received treatment at our hospital are 
summarized in this report. 
We reviewed the hospital records of all 88 adult 
patients (> 16 years, 56 men, 32 women) with a clinical 
diagnosis of tetanus managed at the Dicle University 
Hospital over a 10-year period. Cases were included in 
this series if they fulfilled the following criteria; a 
disease the onset of which was characterized by muscle 
rigidity and hyperreflexia, with a normal conscious 
state, and which could not be explained on the other 
grounds, the subsequent course being consistent with 
tetanus, and there being no history of poisoning with 
strychnine [5]. The following factors were analyzed: 
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age, sex, immunization status, incubation period, type 
and location of wounds, presentation symptoms, 
clinical course, treatment, complications and mortality. 
The factors that might be expected to influence 
mortality were compared using the Kruskal-Wallis test. 
The incubation period is defined as the time between 
the injury and the onset of clinical symptoms. 
Cases were distributed unevenly through the 12 
months of the year. The mean age of the patients was 
36.5215.3 years. The majority of tetanus cases 
occurred in two decades of life: 16-19 years (17 
patients) and 40-49 years (24 patients) (Figure 1). The 
mortality rate was 29% (14/48) in patients under age 
40, and 55% (22/40) in patients over age 40, and the 
difference was statistically significant between the two 
groups by the chi-squared test (p<0.05). The overall 
mortality was 41% (36 cases: 22 male and 14 female). 
The immunization status of 46 (52%) patients was 
known and only six (7%) of them had received tetanus 
toxoid recently. Fifty-six patients (64%) sought initial 
treatment for their wounds, but only eight (9%) of 
them had received their first active immunization after 
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Figure 1 Age distribution and mortality of 88 patients with tetanus. 
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injury. One  of them received passive immunization 
with equine antiserum. The other 32 patients (36%) 
sought no medical help for their wounds. 
There were 38 patients (43%) in whom the in- 
cubation period was 1 week or less. Twenty-two (57%) 
of them died. Wounds producing tetanus were located 
on the lower extremity in 27 (31%) patients, upper 
extremity in 19 (21%), head in 11 (13%), and trunk in 
nine (10%). The infection occurred postpartum in 
eight (9%) and postoperatively in six (7%) patients. 
There was no recognized source in eight patients (9%) 
and two of these died. Wounds producing tetanus were 
categorized as severe, moderate or mild. A mild wound 
was a clean-looking superficial laceration or puncture 
wound; a moderate wound was any superficial wound 
exhibiting cellulitis or purulence, and a severe wound 
was any wound in which necrotic gangrene, crepitation 
or extension of injury below subcutaneous fat was 
observed [6].  
There were 28 patients with a mild wound, of 
whom eight died (29%), 20 patients with a moderate 
wound, of whom 10 died (50%), and 32 patients 
with a severe wound, of whom 16 died (50%). The 
mortalities in each category ofwound severity were not 
significantly different (p>0.05). The two factors that 
influenced the mortality rate were age above 40 
(pz0.012) and infection period shorter than 1 week 
( p = 0.009) . 
The most common first symptom was trisinus. 
Thirty-five patients had neck stiffness, 29 muscle spasm, 
22 general rigidity, 17 risus sardonicus, 16 fever, 15 
opisthotonos, 12 dysphagia, 10 abdominal wall rigidity 
and four agitation. 
All of the patients received penicillin G and 
approximately 6000-10 000 units of tetanus immuno- 
globulin or 50 000-100 000 units of equine antiserum. 
Local early debrideinent and removal of exogenous 
debris were undertaken in 27 patients (31%). Fifty-five 
patients (62%) received equine antiserum, 33 patients 
(38%) received human origin antiserum and six patients 
(7%) received both. The mortality rates in the two 
groups were not significantly different. 
The main complication of tetanus was autonomic 
instability, which was present in 34 patients (38%); 
cardiorespiratory arrest occurred in 13 patients and 
eight of them &ed. These patients had one or more 
of the following symptoms of autonomic instability: 
tachycardia, labile hypertension, sweating, and skin- 
temperature changes. Pulmonary complications of 
tetanus occurred in 51 patients, but most of these 
complications were minor and transient. 
Unfortunately, tetanus is still an important problem 
in Turkey, especially in the southeastern region, because 
of largely non-immunized populations. Some of the 
patients in this series neglected to seek medical aid €or 
their wounds. The initial management by general 
practitioners was often inadequate. Some of the patients 
had received incomplete tetanus vaccination in early 
life and this may have had a beneficial effect on the 
course of the disease [S]. 
The mean age was not high in this series. The 
cause of this phenomenon was probably related to thc 
existence of non-immunized children and young in 
the population. In our patients there was a significant 
relationship between the patients' age and the mortality 
rate. During 1985-6, mortality rates in the USA were 
only 5% in children and adults under 50 years old, but 
rose to 42% in patients 50 years of age or older [7-91. 
In severe tetanus, mortality may reach as high as 
6096, even in experienced centers [3,10]. The overall 
high mortality in our series (41%) may be explained by 
the absence of prior vaccination or tetanus toxoid 
administration after wounding, the poor immunization 
status, the late specific therapy and the inadequacy of 
the intensive care unit conditions. 
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Endocarditis in a Dutch patient caused by Bartonella 
quintana 
Clin Microbiol Infect 1997; 3: 692-695 
Spach et al, in 1993, were the first to describe the 
isolation of Bartonella quintana from an HIV-infected 
patient with endocarditis [l]. Since then, several groups 
have reported cases of endocarditis in immuno- 
competent patients caused by Bartonella quintana (in the 
majority of cases), Bartonella henselae, or Bartonella 
elizabethae (one case) [2-111. Diagnosis was based on 
culture, serologic studies or polymerase chain reaction 
(PCR) detection. Here we report the detection and 
identification of Burtonella quintana in the aortic valve 
of a Dutch patient with culture-negative endocarditis. 
A 74-year-old man (not homeless or otherwise 
neglected) was admitted to hospital because of general 
malaise, weight loss and leukocytosis. A year earlier, 
he had been bitten by an insect on the ankle, which 
remained swollen for several weeks. The patient did 
not own domestic animals. No further abnormalities, 
especially no heart murmurs, were found on physical 
examination. In the days following admission, his 
temperature rose to 39°C and his condition deterio- 
rated. Laboratory investigations showed an erythrocyte 
sedimentation rate (ESR) of 70 mm/h, hemoglobin 
5.7 mmol/L, thrombocytes 179 x 10”L and leukocytes 
40.2 x 109/L. Liver hnction tests and ECG were normal. 
Bacteriologic cultures of urine, bone marrow and 
multiple blood samples were negative. Bone marrow 
examination indicated myeloproliferative activity, with- 
out the typical picture of chronic myeloid leukemia. 
Cytogenetic examination did not reveal a Philadelphia 
translocation. Serologic tests for lkponema pallidum 
and Coxiella burnetii were negative. However, a Borrelia 
burgdoferi-specific imrnunofluorescence assay (IFA) 
revealed an antibody titer of 1:1280. Because the 
general condition of the patient gradually worsened, 
and because of the positive Borrelia serology, empirical 
intravenous treatment with amoxicillin-clavulanic acid 
was started. Following this treatment, the condition 
of the patient improved and the leukocyte count 
normalized. Antibiotic treatment of the patient was 
continued using oral amoxicillin 500 mg three times 
daily for 4 weeks. ESR and leukocyte count reached 
their lowest levels of 36 mm/h and 9.7 x 109/L, respec- 
tively, at 6 months after adrmssion; leukocyte differen- 
tiation at that point was normal. Seven months after the 
first hospitalization, the patient was readmitted to the 
hospital with complaints of dyspnea and tiredness. At 
this stage, a heart murmur was heard. A chest X-ray 
showed cardiomegaly, a pleural effusion and inter- 
stitial edema. The leukocyte count had risen to 
30.4 x 1OY/L. Ultrasound examination of the heart 
showed mitral valve insufficiency and severe aortic 
valve insufficiency with valvular vegetations, indicating 
endocarditis. Despite intravenous treatment with ampi- 
cdlin and gentamicin, the patient developed fever, renal 
insufficiency, and increasing cardiac failure. He under- 
went valve replacement and hemodialysis. Microscopic 
examination of the aortic valve revealed the presence 
of sclerotic vegetations, but there was no indication of 
active endocarditis. The patient died 3 weeks after 
surgery, from septicemia and pulmonary hemorrhage. 
Within a 9-month period in 1995, five serum 
samples were taken from the patient. All sera were 
tested for the presence of IgG and IgM antibodies 
against Bartonella, in an enzyme-linked immunoassay 
(EIA) using Bartonella henselae (ATCC 49882) and 
Bartonella quintana (90-268) as antigens, and in an IFA 
using Bartonella henselae (ATCC 49882) as antigen 
(Table 1) [12]. Although the Borrelia-specific IFA 
Table 1 Serologic results of sera horn a patient with Bartonella quintam endocardtis 
EIA IgG EIA IgM EIA IgG EIA IgM IFA IgG IFA IgM 
Date B. kenrelac B. kenrelae B. quintana B. quintana B. henrelae B. henselae 
22/03/95 73 600 200 19 000 288 NT 32-64 
30/03/95 61 700 200 17 100 273 NT 32-64 
03/11/95 80 300 218 17 800 370 NT >=128 
13/11/95 82 500 200 16300 323 NT >=128 
04/12/95 103 400 200 19 500 206 >=256 32 
NT, titer could not be determined because of high background. 
